- Home
- CLRO vs IMRN Comparison
CLRO vs IMRN Comparison
Compare CLRO & IMRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLRO
- IMRN
- Stock Information
- Founded
- CLRO 1983
- IMRN 1994
- Country
- CLRO United States
- IMRN Australia
- Employees
- CLRO N/A
- IMRN N/A
- Industry
- CLRO Radio And Television Broadcasting And Communications Equipment
- IMRN Biotechnology: Pharmaceutical Preparations
- Sector
- CLRO Technology
- IMRN Health Care
- Exchange
- CLRO Nasdaq
- IMRN Nasdaq
- Market Cap
- CLRO 13.9M
- IMRN 15.0M
- IPO Year
- CLRO N/A
- IMRN N/A
- Fundamental
- Price
- CLRO $0.59
- IMRN $2.25
- Analyst Decision
- CLRO
- IMRN Strong Buy
- Analyst Count
- CLRO 0
- IMRN 1
- Target Price
- CLRO N/A
- IMRN $5.00
- AVG Volume (30 Days)
- CLRO 17.2K
- IMRN 7.2K
- Earning Date
- CLRO 11-07-2024
- IMRN 10-22-2024
- Dividend Yield
- CLRO 85.47%
- IMRN N/A
- EPS Growth
- CLRO N/A
- IMRN N/A
- EPS
- CLRO N/A
- IMRN N/A
- Revenue
- CLRO $14,969,000.00
- IMRN $3,271,194.00
- Revenue This Year
- CLRO N/A
- IMRN N/A
- Revenue Next Year
- CLRO N/A
- IMRN N/A
- P/E Ratio
- CLRO N/A
- IMRN N/A
- Revenue Growth
- CLRO N/A
- IMRN 171.67
- 52 Week Low
- CLRO $0.53
- IMRN $1.48
- 52 Week High
- CLRO $2.48
- IMRN $5.96
- Technical
- Relative Strength Index (RSI)
- CLRO 45.82
- IMRN 32.37
- Support Level
- CLRO $0.56
- IMRN $2.66
- Resistance Level
- CLRO $0.64
- IMRN $2.73
- Average True Range (ATR)
- CLRO 0.03
- IMRN 0.19
- MACD
- CLRO -0.00
- IMRN -0.06
- Stochastic Oscillator
- CLRO 31.25
- IMRN 24.04
About CLRO ClearOne Inc. (DE)
ClearOne Inc is a communications solutions company, which is engaged in designing, developing, and selling conferencing, collaboration, streaming, and digital signage solutions for audio, video, and visual communication. It sells its commercial products to end-users predominantly through a network of independent distributors, who in turn sell its products to dealers, systems integrators, and other resellers. Its products include DSP mixers, amplifiers, Video walls, professional cameras, and professional microphones among others. Geographically the firm has its business presence across the United States and international markets.
About IMRN Immuron Limited
Immuron Ltd is a clinical-stage biopharmaceutical company focused on the development and commercialization of a novel class of immunomodulator polyclonal antibodies to treat liver diseases, infectious diseases and other immune-mediated diseases, such as colitis. The company's product, IMM-124E, is a proprietary immunomodulatory agent targeted at GI immune-mediated diseases including fatty liver diseases. The company functions in two segments namely, Research and Development and Hyperimmune products.